|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Krishnan V, Berek JS and Dorigo O:
Immunotherapy in ovarian cancer. Curr Probl Cancer. 41:48–63. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xie F, Yuan Y, Xie L, Ran P, Xiang X,
Huang Q, Qi G, Guo X, Xiao C and Zheng S: miRNA-320a inhibits tumor
proliferation and invasion by targeting c-Myc in human
hepatocellular carcinoma. Onco Targets Ther. 10:885–894. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hu Y, Xie H, Liu Y, Liu W, Liu M and Tang
H: miR-484 suppresses proliferation and epithelial-mesenchymal
transition by targeting ZEB1 and SMAD2 in cervical cancer cells.
Cancer Cell Int. 17:362017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gao Y, Lin L, Li T, Yang J and Wei Y: The
role of miRNA-223 in cancer: Function, diagnosis and therapy. Gene.
616:1–17. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Arechaga-Ocampo E, Lopez-Camarillo C,
Villegas-Sepulveda N, Gonzalez-De la Rosa CH, Perez-Añorve IX,
Roldan-Perez R, Flores-Perez A, Peña-Curiel O, Angeles-Zaragoza O,
Rangel Corona R, et al: Tumor suppressor miR-29c regulates
radioresistance in lung cancer cells. Tumour Biol.
39:10104283176950102017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang W, Yang J, Xiang YY and Pi J:
Overexpression of Hsa-miR-320 Is associated with invasion and
metastasis of ovarian cancer. J Cell Biochem. 118:3654–3661. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu J, Jiang N, Shi H, Zhao S, Yao S and
Shen H: miR-28-5p promotes the development and progression of
ovarian cancer through inhibition of N4BP1. Int J Oncol. Mar
16–2017.(Epub ahead of print). View Article : Google Scholar
|
|
9
|
Bai L, Wang H, Wang AH, Zhang LY and Bai
J: MicroRNA-532 and microRNA-3064 inhibit cell proliferation and
invasion by acting as direct regulators of human telomerase reverse
transcriptase in ovarian cancer. PLoS One. 12:e01739122017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pan Y, Robertson G, Pedersen L, Lim E,
Hernandez-Herrera A, Rowat AC, Patil SL, Chan CK, Wen Y, Zhang X,
et al: miR-509-3p is clinically significant and strongly attenuates
cellular migration and multi-cellular spheroids in ovarian cancer.
Oncotarget. 7:25930–25948. 2016.PubMed/NCBI
|
|
11
|
Zhang J, Liu L, Sun Y, Xiang J, Zhou D,
Wang L, Xu H, Yang X, Du N, Zhang M, et al: MicroRNA-520 g promotes
epithelial ovarian cancer progression and chemoresistance via DAPK2
repression. Oncotarget. 7:26516–26534. 2016.PubMed/NCBI
|
|
12
|
Wu AH, Huang YL, Zhang LZ, Tian G, Liao QZ
and Chen SL: MiR-572 prompted cell proliferation of human ovarian
cancer cells by suppressing PPP2R2C expression. Biomed
Pharmacother. 77:92–97. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xia B, Li H, Yang S, Liu T and Lou G:
MiR-381 inhibits epithelial ovarian cancer malignancy via YY1
suppression. Tumour Biol. 37:9157–9167. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cao C, Sun D, Zhang L and Song L: miR-186
affects the proliferation, invasion and migration of human gastric
cancer by inhibition of Twist1. Oncotarget. 7:79956–79963. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lei ST, Shen F, Chen JW, Feng JH, Cai WS,
Shen L, Hu ZW and Xu B: MiR-639 promoted cell proliferation and
cell cycle in human thyroid cancer by suppressing CDKN1A
expression. Biomed Pharmacother. 84:1834–1840. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fu X, Li Y, Alvero A, Li J, Wu Q, Xiao Q,
Peng Y, Hu Y, Li X, Yan W, et al: MicroRNA-222-3p/GNAI2/AKT axis
inhibits epithelial ovarian cancer cell growth and associates with
good overall survival. Oncotarget. 7:80633–80654. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wen Z, Zhao S, Liu S, Liu Y, Li X and Li
S: MicroRNA-148a inhibits migration and invasion of ovarian cancer
cells via targeting sphingosine-1-phosphate receptor 1. Mol Med
Rep. 12:3775–3780. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Baez-Vega PM, Echevarria Vargas IM,
Valiyeva F, Encarnación-Rosado J, Roman A, Flores J,
Marcos-Martínez MJ and Vivas-Mejía PE: Targeting miR-21-3p inhibits
proliferation and invasion of ovarian cancer cells. Oncotarget.
7:36321–36337. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xiaohong Z, Lichun F, Na X, Kejian Z,
Xiaolan X and Shaosheng W: MiR-203 promotes the growth and
migration of ovarian cancer cells by enhancing glycolytic pathway.
Tumour Biol. 37:14989–14997. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zeng LP, Hu ZM, Li K and Xia K: miR-222
attenuates cisplatin-induced cell death by targeting the
PPP2R2A/Akt/mTOR Axis in bladder cancer cells. J Cell Mol Med.
20:559–567. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zeng LP, Hu ZM, Li K and Xia K: miR-222
attenuates cisplatin-induced cell death by targeting the
PPP2R2A/Akt/mTOR Axis in bladder cancer cells. J Cell Mol Med.
20:559–567. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hein AL, Seshacharyulu P, Rachagani S,
Sheinin YM, Ouellette MM, Ponnusamy MP, Mumby MC, Batra SK and Yan
Y: PR55α subunit of protein phosphatase 2A supports the tumorigenic
and metastatic potential of pancreatic cancer cells by sustaining
hyperactive oncogenic signaling. Cancer Res. 76:2243–2253. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Y, Ma T, Yang S, Xia M, Xu J, An H,
Yang Y and Li S: High-mobility group A1 proteins enhance the
expression of the oncogenic miR-222 in lung cancer cells. Mol Cell
Biochem. 357:363–371. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shen S, Yue H, Li Y, Qin J, Li K, Liu Y
and Wang J: Upregulation of miR-136 in human non-small cell lung
cancer cells promotes Erk1/2 activation by targeting PPP2R2A.
Tumour Biol. 35:631–640. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu X, Sempere LF, Ouyang H, Memoli VA,
Andrew AS, Luo Y, Demidenko E, Korc M, Shi W, Preis M, et al:
MicroRNA-31 functions as an oncogenic microRNA in mouse and human
lung cancer cells by repressing specific tumor suppressors. J Clin
Invest. 120:1298–1309. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liang WL, Cao J, Xu B, Yang P, Shen F, Sun
Z, Li WL, Wang Q and Liu F: miR-892a regulated PPP2R2A expression
and promoted cell proliferation of human colorectal cancer cells.
Biomed Pharmacother. 72:119–124. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wong QW, Ching AK, Chan AW, Choy KW, To
KF, Lai PB and Wong N: MiR-222 overexpression confers cell
migratory advantages in hepatocellular carcinoma through enhancing
AKT signaling. Clin Cancer Res. 16:867–875. 2010. View Article : Google Scholar : PubMed/NCBI
|
